Differences between first wave and second wave of COVID-19 in India
The recent wave of corona virus is spreading like a 'tsunami'in India. As on April 23, 2021,
the COVID-19 cases have crossed the 15.9 million, with 1, 85,000 deaths. The 2nd wave is …
the COVID-19 cases have crossed the 15.9 million, with 1, 85,000 deaths. The 2nd wave is …
[HTML][HTML] Clinical considerations for patients with diabetes in times of COVID-19 epidemic
R Gupta, A Ghosh, AK Singh, A Misra - Diabetes & metabolic …, 2020 - ncbi.nlm.nih.gov
COVID-19 (Coronavirus Disease-2019), a disease caused by the coronavirus SARS-CoV-2
(Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading …
(Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading …
[HTML][HTML] A wave of non-communicable diseases following the COVID-19 pandemic
MA Lim, I Huang, E Yonas, R Vania… - Diabetes & metabolic …, 2020 - ncbi.nlm.nih.gov
Patients with chronic diseases who need life-long medications may find it difficult to reach
medical services during the coronavirus disease 2019 (COVID-19) pandemic. The problem …
medical services during the coronavirus disease 2019 (COVID-19) pandemic. The problem …
[PDF][PDF] Newly diagnosed diabetes in COVID-19 patients
To the Editor, The article by Papadokostaki et al. in the recent issue of Primary Care
Diabetes has highlighted several critical issues related to the bi-directional relationship …
Diabetes has highlighted several critical issues related to the bi-directional relationship …
Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic …
A Ghosh, RM Anjana, CSS Rani, SJ Rani… - Diabetes & Metabolic …, 2021 - Elsevier
Background and aims It is not known if new onset diabetes during Coronavirus-19 disease
(COVID-19; NOD COVID) is phenotypically or biochemically different than new onset …
(COVID-19; NOD COVID) is phenotypically or biochemically different than new onset …
[HTML][HTML] Commentary: COVID-19 in patients with diabetes
MA Hill, C Mantzoros, JR Sowers - Metabolism, 2020 - ncbi.nlm.nih.gov
The spread of the novel SARS-CoV-2 coronavirus (COVID-19) has reached pandemic
proportions and represents a threat for increased morbidity and mortality, globally. In many …
proportions and represents a threat for increased morbidity and mortality, globally. In many …
COVID-19: From bench to bed side
A Singh, A Shaikh, R Singh, AK Singh - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims The last two decades have experienced the outbreaks of three
different coronaviruses in the different parts of the world namely; Severe acute respiratory …
different coronaviruses in the different parts of the world namely; Severe acute respiratory …
COVID-19 pandemic and its recovery time of patients in India: A pilot study
Background and aims Covid-19 virus started from Wuhan, China and has brought the world
down to its knees. It has catapulted as a venomous global phenomenon. This study focuses …
down to its knees. It has catapulted as a venomous global phenomenon. This study focuses …
Newly diagnosed diabetes in patients with mild to moderate COVID-19
T Sathish, MC Anton - Diabetes & Metabolic Syndrome: Clinical Research & …, 2021 - Elsevier
Background and aims We aimed to study newly diagnosed diabetes in patients with mild to
moderate COVID-19. Methods This was a retrospective cohort study of COVID-19 patients …
moderate COVID-19. Methods This was a retrospective cohort study of COVID-19 patients …
COVID-19 and diabetes: The why, the what and the how
S Cuschieri, S Grech - Journal of Diabetes and its Complications, 2020 - Elsevier
Background The novel coronavirus SARS-CoV-2 has taken the world by storm. Alongside
COVID-19, diabetes is a long-standing global epidemic. The diabetes population has been …
COVID-19, diabetes is a long-standing global epidemic. The diabetes population has been …